Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Phase NA Completed
3,228 enrolled 41 charts
PRIMM
Phase 2 Completed
50 enrolled
Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)
Phase 2 Completed
30 enrolled
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Phase 1/2 Completed
307 enrolled 27 charts
MESODEC
Phase 1/2 Completed
28 enrolled
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
Phase 3 Completed
790 enrolled 1 FDA
CLASSIC5
Phase 2 Completed
112 enrolled
Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)
Phase 3 Completed
166 enrolled 20 charts
Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients
Phase 3 Completed
95 enrolled 27 charts
Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
Completed
209 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Phase 3 Completed
232 enrolled
Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients
Phase NA Completed
114 enrolled
TRISS
Phase NA Completed
235 enrolled
G-DEFINER
Completed
247 enrolled
CHIVA
Phase 2 Completed
61 enrolled
eNERGY
Phase 3 Completed
217 enrolled
A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC
Phase 3 Completed
465 enrolled
A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
44 enrolled 16 charts
Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Completed
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Completed
106 enrolled 13 charts
MK 01
Phase 2 Completed
31 enrolled
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase 1 Completed
60 enrolled 15 charts
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
Phase NA Completed
70 enrolled
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
Phase 2 Completed
69 enrolled 10 charts
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
Phase 2 Completed
99 enrolled
Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy
Phase 2 Completed
60 enrolled
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Phase NA Completed
100 enrolled
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
Phase 2 Completed
18 enrolled
CERTO
Phase 2 Completed
232 enrolled 17 charts
Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer
Completed
82 enrolled
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
Phase 3 Completed
366 enrolled
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer
Phase 2 Completed
12 enrolled
Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC
Phase 2 Completed
71 enrolled 7 charts
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer
Phase 1/2 Completed
180 enrolled 13 charts
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
Phase 3 Completed
217 enrolled 11 charts
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
Phase 1 Completed
23 enrolled
Once Weekly Radiation for Lung Cancer With Chemotherapy
Phase NA Completed
26 enrolled
Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study
Phase 1/2 Completed
35 enrolled
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
Phase 3 Completed
251 enrolled
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
Phase 1 Completed
6 enrolled
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Phase 2/3 Completed
150 enrolled
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Phase 1 Completed
20 enrolled
First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker
Phase 3 Completed
315 enrolled
CPG 7909 Injection in Non-Small Cell Lung Cancer
Phase 2 Completed
116 enrolled
Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC
Phase 1 Completed
15 enrolled
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
Phase 1/2 Completed
20 enrolled